Source: Eur Respir Monogr 2021; 91: 134-143
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew J. Thorley, Jason R. Rock. Mesenchymal cells, immune cells and the lung stem cell niche. Eur Respir Monogr 2021; 91: 134-143

Member's Comments

No comment yet.

Related content which might interest you: Lung stem cells and the role of the stem cell niche Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung Year: 2019 Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 190-204 Year: 2021 Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Embryonic stem cells as source for endothelial cells for cell-based therapies Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 PP127 – Three-dimensional niches for the physiological-like expansion of a lung mesenchymal stromal cell subpopulation Source: ERS Lung Science Conference 2021 Year: 2021 Modelling human lung development and disease using pluripotent stem cells Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats Year: 2015 Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair Source: ERS Lung Science Conference 2020 Year: 2020 Using induced pluripotent stem cells to model the human lung alveolar epithelium Source: International Congress 2018 – Pathophysiology of the human lung alveolus Year: 2018 LSC - 2021 - Three-dimensional niches for the physiological-like expansion of a lung mesenchymal stromal cell subpopulation Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017 Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Derivation of epithelial-only airway organoids from human pluripotent stem cells Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside Year: 2019